Introduction
MyLifeBak aims to become the ‘first-of-its kind’ functional foods company offering a full-range of multi-herbal foods, that act as an anti-viral, prebiotic-enriched, anti-inflammatory.
The efficacy of our product offerings will help people attain homeostasis by supporting overall gut health, so we can then achieve optimal performance and ‘self-heal’.
Our PATENTED whole hemp-flower process, infuses hemp botanicals with various essential-oils and prebiotics, along with other proven anti-viral and anti-inflammatory supplements.
Thus, our innovative multi-herbal infusion and encapsulation process enhances the synergies found in the ‘entourage effect’, so as to target all of the organs while enlivening the ‘good’ bacteria found in our guts.
Bottom line, our products will be proven to help people with sleep, weight-loss, inflammation, anxiety, depression, malnutrition, addiction, exercise recovery, and even Covid-19…
Our patented process decarboxylates the cannabinoids, preserves the terpenoids and flavonoids, and includes the plant material in the final product. Thus, we are the only 'FDA and DEA Legal' Hemp dietary supplement, and we are at least 10X more effective than our competition.
The efficacy of our product offerings will help people attain homeostasis by supporting overall gut health, so we can then achieve optimal performance and ‘self-heal’.
Our PATENTED whole hemp-flower process, infuses hemp botanicals with various essential-oils and prebiotics, along with other proven anti-viral and anti-inflammatory supplements.
Thus, our innovative multi-herbal infusion and encapsulation process enhances the synergies found in the ‘entourage effect’, so as to target all of the organs while enlivening the ‘good’ bacteria found in our guts.
Bottom line, our products will be proven to help people with sleep, weight-loss, inflammation, anxiety, depression, malnutrition, addiction, exercise recovery, and even Covid-19…
Our patented process decarboxylates the cannabinoids, preserves the terpenoids and flavonoids, and includes the plant material in the final product. Thus, we are the only 'FDA and DEA Legal' Hemp dietary supplement, and we are at least 10X more effective than our competition.
Convertible Note
25% Discount of the DCF Valuation @ 11% Interest
A convertible note is a form of short-term debt that converts into equity, typically in conjunction with a future financing round; in effect, the investor would be loaning money to a startup and instead of a return in the form of principal plus interest, the investor would receive equity in the company.
The primary advantage of issuing convertible notes is that it does not force the issuer and investors to determine the value of the company when there really might not be much to base a valuation on – in some cases the company may just be an idea. That valuation will usually be determined during the Series A financing, when there are more data points off which to base a valuation.
Convertible Note Terms
When evaluating a convertible note, there are a few key parameters that must be kept in mind:
Discount Rate
This represents the valuation discount you receive relative to investors in the subsequent financing round, which compensates you for the additional risk you bore by investing earlier.
Valuation Cap
The valuation cap is an additional reward for bearing risk earlier on. It effectively caps the price at which your notes will convert into equity and – in a way – provides convertible note holders with equity-like upside if the company takes off out of the gate.
Interest rate
Since you are lending money to a company, convertible notes will more often than not accrue interest as well. However, as opposed to being paid back in cash, this interest accrues to the principal invested, increasing the number of shares issued upon conversion.
Maturity date
This denotes the date on which the note is due, at which time the company needs to repay it; either via the conversion of the accrued debt into equity; or the entire loan amount is repaid, plus accrued interested.
The primary advantage of issuing convertible notes is that it does not force the issuer and investors to determine the value of the company when there really might not be much to base a valuation on – in some cases the company may just be an idea. That valuation will usually be determined during the Series A financing, when there are more data points off which to base a valuation.
Convertible Note Terms
When evaluating a convertible note, there are a few key parameters that must be kept in mind:
Discount Rate
This represents the valuation discount you receive relative to investors in the subsequent financing round, which compensates you for the additional risk you bore by investing earlier.
Valuation Cap
The valuation cap is an additional reward for bearing risk earlier on. It effectively caps the price at which your notes will convert into equity and – in a way – provides convertible note holders with equity-like upside if the company takes off out of the gate.
Interest rate
Since you are lending money to a company, convertible notes will more often than not accrue interest as well. However, as opposed to being paid back in cash, this interest accrues to the principal invested, increasing the number of shares issued upon conversion.
Maturity date
This denotes the date on which the note is due, at which time the company needs to repay it; either via the conversion of the accrued debt into equity; or the entire loan amount is repaid, plus accrued interested.
